Development of a novel PSMA-targeting small molecule-Thorium-227 conjugate for the treatment of prostate cancer

被引：0
|
作者：
Boehnke, Niels [1 ]
Indrevoll, Bard [2 ]
Hammer, Stefanie [1 ]
Papple, Alex [2 ]
Kristian, Alexander [2 ]
Cuthbertson, Alan [2 ]
Zitzmann-Kolbe, Sabine [1 ]
机构：
[1] Bayer AG, Berlin, Germany
[2] Bayer AS, Oslo, Norway
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5440
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Multimeric PSMA-targeting small molecule thorium-227 conjugates for the treatment of prostate cancer
    Papple, A.
    Indrevoll, B.
    Hammer, S.
    Kristian, A.
    Mumberg, D.
    Cuthbertson, A.
    Zitzmann-Kolbe, S.
    Boehnke, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S438 - S438
  • [2] Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models
    Boehnke, Niels
    Indrevoll, Bard
    Hammer, Stefanie
    Papple, Alex
    Kristian, Alexander
    Briem, Hans
    Celik, Arif
    Mumberg, Dominik
    Cuthbertson, Alan
    Zitzmann-Kolbe, Sabine
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 669 - 680
  • [3] Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models
    Niels Böhnke
    Bård Indrevoll
    Stefanie Hammer
    Alex Papple
    Alexander Kristian
    Hans Briem
    Arif Celik
    Dominik Mumberg
    Alan Cuthbertson
    Sabine Zitzmann-Kolbe
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 669 - 680
  • [4] Novel PSMA-Targeting Radionuclide Peptidomimetics for Treating Prostate Cancer
    Chia, C. S. Brian
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (01): : 3 - 4
  • [5] Preclinical pharmacology of the PSMA-targeted thorium-227 conjugate PSMA-TTC: a novel targeted alpha therapeutic for the treatment of prostate cancer
    Hammer, Stefanie
    Larssen, Aasmund
    Ellingsen, Christine
    Geraudie, Solene
    Grant, Derek
    Indrevoll, Baard
    von Ahsen, Oliver
    Kristian, Alexander
    Hagemann, Urs B.
    Karlsson, Jenny
    Bjerke, Roger M.
    Ryan, Olav B.
    Mumberg, Dominik
    Kreft, Bertolt
    Cuthbertson, Alan
    CANCER RESEARCH, 2017, 77
  • [6] Synthesis of a PSMA-targeting ligand with an optimized linker for imaging and treatment of prostate cancer
    Murce, Erika
    Spaan, Evelien
    Seimbille, Yann
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S206 - S207
  • [7] Preclinical evaluation of ePSMA-DM1: a PSMA-targeting theranostic small molecule drug conjugate
    Seimbille, Yann
    Murce, Erika
    Spaan, Evelien
    Beekman, Savanne
    Handula, Maryana
    de Ridder, Corrina
    Stuurman, Debra
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S59 - S60
  • [8] Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective
    Ng, Thomas S. C.
    Gao, Xin
    Salari, Keyan
    Zlatev, Dimitar V.
    Heidari, Pedram
    Kamran, Sophia C.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Application of PSMA-targeting magnetic nanoparticles into MRI of prostate cancer
    Tse, Brian
    Cowin, Gary
    Soekmadji, Carolina
    Jovanovic, Lidija
    Thierry, Benjamin
    Russell, Pamela
    BJU INTERNATIONAL, 2013, 112 : 34 - 35
  • [10] Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
    Hammer, Stefanie
    Hagemann, Urs B.
    Zitzmann-Kolbe, Sabine
    Larsen, Aasmund
    Ellingsen, Christine
    Geraudie, Solene
    Grant, Derek
    Indrevoll, Baard
    Smeets, Roger
    von Ahsen, Oliver
    Kristian, Alexander
    Lejeune, Pascale
    Hennekes, Hartwig
    Karlsson, Jenny
    Bjerke, Roger M.
    Ryan, Olav B.
    Cuthbertson, Alan S.
    Mumberg, Dominik
    CLINICAL CANCER RESEARCH, 2020, 26 (08) : 1985 - 1996
12345